Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Duration of Antibiotic Treatment in Culture Negative Early Onset Infection in Term Born Newborns: A Nationwide Randomized Controlled Non-inferiority Trial.

NCT05329701 is registered in ClinicalTrials.gov with Ulrikka Nygaard as lead sponsor.

NCT NCT05329701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05329701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Duration of Antibiotic Treatment in Culture Negative Early Onset Infection in Term Born Newborns: A Nationwide Randomized Controlled Non-inferiority Trial.
Lead sponsor
Ulrikka Nygaard
Phase
Phase 4
Overall status
Completed
Start date
April 22, 2022
Completion date
August 10, 2025
Enrollment
488 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic side effect, early-onset neonatal sepsis